Request Sample

Global Carrier Screening Market

March 4, 2019

Global Carrier Screening Market, By Test Type (Expanded Carrier Screening (Customized Panel Testing and Predesigned Panel Testing) and Targeted Disease Carrier Screening), By Disease Type (Cystic Fibrosis, Sickle Cell Disease, Spinal Muscular Atrophy, Tay-Sachs, Gaucher Disease, Fragile X Syndrome, Thalassemia, and Others), By End User (Hospitals, Physician Offices & Clinics, Reference Laboratories, and Others), Region (North America, Latin America, Europe, Asia-Pacific, Middle East and Africa)- Global Forecast, 2020-2025.

Report Code :FMR495      
Pages :193 Pages
Format :   PPT Format   PDF Format

The global carrier screening market was valued at US$ xx million in the year 2019. This market is estimated to be valued at US$ xx million in the year 2020 and is expected to reach US$ xx million by the year 2025, with an estimated CAGR of xx% during the forecast period (2020-2025). Carrier screening is a testing process which provides a facility to an individual to understand any genetic disorder. The carrier screening is mostly done before or during the pregnancy to test any genetic disorder and avoiding the risk of transferring the disease to the newborn. It can be done for evaluating genetic disorders such as sickle cell disease, tay-sachs, fragile X syndrome, and cystic fibrosis.

Table 1. Global Carrier Screening Market Synopsis

Parameters

Description

Market Value (US$ Mn) for the Period

2018-2025

Base Year

2019

Forecast Period

2020-2025

Market Segmentation (By Test Type)

Expanded Carrier Screening (Customized Panel Testing and Predesigned Panel Testing) and Targeted Disease Carrier Screening

Market Segmentation (By Disease Type)

Cystic Fibrosis, Sickle Cell Disease, Spinal Muscular Atrophy, Tay-Sachs, Gaucher Disease, Fragile X Syndrome, Thalassemia, and Others

Market Segmentation (By End User)

Hospitals, Physician Offices & Clinics, Reference Laboratories, and Others

Regions Covered

North America, Latin America, Europe, Asia-Pacific, Middle East and Africa

Key Players Coverage

Thermo Fisher Scientific, Invitae, Myriad Genetics, OPKO Health, Quest Diagnostics, Sema4, Illumina, Fulgent Genetics, Eurofins Scientific, Cepheid, Luminex, Abbott Laboratories, Andme Inc., Roche Holding Ag, Pathway Genomics Corporation, Gene by Gene, 23andMe Inc., Natera, BGI, and CENTOGENE AG, among others

Key Insights

  • Latest Updates
  • Analyst Views
  • Future Outlook of the Market

Market Dynamics

The maternal age of the women has been rising significantly, especially in the countries like the U.S., Japan, France, Italy, Germany, and others. The factors like financial stability, increasing age of marriage, rise in literacy rate, etc. are advancing the maternal age that leads to the risk of fetal chromosomal disorder and therefore, enhance the demand for carrier screening market. For instance, in October 2016, according to the American Academy of Family Physicians (AAFP), the growth in the average maternal age leads to the risk of fetal chromosomal disorder and which moderately increases up to the age of 30; this is expected to raise the carrier screening market growth.

The advancement in technology in healthcare industry for understanding the risk of genetic diseases and evolving the methods and process to prevent them are the major factors to drive the growth of the carrier screening market. For instance, in March 2015, Recombine, a clinical genetic testing company launched the CarrierMap test (a carrier screen to test more than 250 genetic diseases in patients) and collaborated with Sequenom Laboratories to expand the carrier screening technology globally.

However, the lack of awareness and resources for implementation of carrier screening test are expected to hinder the carrier screening market over the forecast period.

Figure 1. PORTER’S Analysis

 

Note: The above figure is shown for illustrative purposes only, the actual data may vary and will be incorporated in the report.

North America has envisaged to witness the lucrative growth opportunity of the carrier screening market, owing to the well-developed health infrastructure, improvement and innovations in the diagnosis, treatment, and prevention of disease in the region. For instance, in October 2019, the company, Sema4 declared the launch of expanded carrier screening to deliver enhanced risk assessment and low-pass genome analysis for detection of risks and better future planning decisions.

Moreover, the rise in the technology and the applications of genetics sequencing are expected to foster the growth of the carrier screening market in the Asia-Pacific region. For instance, in March 2017, MedGenome company launched the Claria Carrier screening test that is based on the NGS (Next Generation Sequencing) technology and helps to provide the better understanding of the risks of genetic disorder and the solutions to treat them.

Figure 2. Regional Analysis

 

Note: The above figure is shown for illustrative purposes only, the actual data may vary and will be incorporated in the report.

Competitive Landscape

Key players in the global carrier screening market include Thermo Fisher Scientific, Invitae, Myriad Genetics, OPKO Health, Quest Diagnostics, Sema4, Illumina, Fulgent Genetics, Eurofins Scientific, Cepheid, Luminex, Abbott Laboratories, Andme Inc., Roche Holding Ag, Pathway Genomics Corporation, Gene By Gene, 23andMe Inc., Natera, BGI, and CENTOGENE AG, among others

The carrier screening market players are following various strategies like product development, innovation, collaboration, and acquisition to become the leading player of the market. For instance, in August 2017, the company, Invitae made an acquisition with Good Start Genetics to enable reproductive health genetic testing to its portfolio and strengthening its position in the carrier screening market.

Further, in January 2018, the company, OPKO’s GeneDx collaborated with Radboud University Medical Center for research purpose to identify and understand the genetic disorder cause and therefore, diagnose patients with such disorder.

Figure 3. Market Share of Key Players, 2019

 

Note: The above figure is shown for illustrative purposes only, the actual data may vary and will be incorporated in the report.

By Test Type

  • Expanded Carrier Screening
  • Customized Panel Testing
  • Predesigned Panel Testing
  • Targeted Disease Carrier Screening

By Disease Type

  • Cystic Fibrosis
  • Sickle Cell Disease
  • Spinal Muscular Atrophy
  • Tay-Sachs
  • Gaucher Disease
  • Fragile X Syndrome
  • Thalassemia     
  • Others

By End User

  • Hospitals
  • Physician Offices & Clinics
  • Reference Laboratories
  • Others

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa 
rm
Kindly fill the below form and we will contact you within 24 hours
I have read and accept Privacy Policy

Confidentiality

We respect your privacy rights and safeguard your personal information. We prevent the disclosure of personal information to third parties.

Note: This report provides in-depth analysis of the global carrier screening market and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2020-2025), considering 2019, as the base year.

  • What are the trends adopted by key players in the global carrier screening market?
  • What key factors are expected to increase the demand for carrier screening market during the forecast period 2020-2025?
  • What are the major challenges inhibiting the growth of the global carrier screening market?
  • What is the total market value (US$ Mn) generated in global carrier screening market by test type in 2019 and what are the forecasts by 2025?
  • Which disease type is expected to propel the carrier screening market in the foreseen future?
  • Which end user contributes highest CAGR (%) in the carrier screening bank market?
  • What was the total revenue generated by the global carrier screening market across different regions (North America, Europe, Asia-Pacific, Latin America, and Middle East and Africa) in 2019, along with CAGR (%) for the period (2020-2025)?
  • Who are the key players contributing to the growth of the global carrier screening market, and what are the new strategies adopted by them to retain a market share in the industry?
  • What is the competitive strength of the key players in the carrier screening market?
  • What are the major outcomes derived from the Porter’s five forces?
  • What new products are going to be approved or launched in the coming years which may have huge impact on the market?
  • What insights are derived through the analysis of key players on following parameters: company overview, financial performance, product portfolio, geographical presence, key highlights, and strategies?

Latest Reports

Global Sleep Testing Services Market

Global Sleep Testing Services Market, By Test Type (Home Sleep Testing and In-lab Sleep Testing (Electroencephalogram, Full Polysomnography, CPAP/BiPAP …

Read More

Global Sarcoma Biopsy Market

Global Sarcoma Biopsy Market, By Product Type (Reusable Device, Disposable Devices), By End User (Hospitals, Ambulatory Surgical Centers, Diagnostic …

Read More

Global Rheumatoid Arthritis Diagnostic Tests Market

Global Rheumatoid Arthritis Diagnostic Tests Market, By Test Type (serology tests (erythrocyte sedimentation rate (ESR), rheumatoid factor (RF), anti-cyclic …

Read More

Global PARP Inhibitor Biomarkers Market

Global PARP Inhibitor Biomarkers Market, By Product and Service Type (Product Type, (Kits, Assays), Service Type, (BRCA 1 & …

Read More

North America Outbound Medical Tourism Services Market

North America Outbound Medical Tourism Services Market, By Treatment Type (Cardiovascular Treatment, Cosmetic Surgery Treatment, Dental Treatment, Weight Loss …

Read More

Global Methicillin Resistant Staphylococcus Aureus (MRSA) Testing Systems Market

Global Methicillin Resistant Staphylococcus Aureus (MRSA) Testing Systems Market, By Product Type (Instruments and Reagents and Kits ), By …

Read More

Global Bilirubin Blood Test Market

Global Bilirubin Blood Test Market, By Test Type (Direct/Conjugated Bilirubin Test, Indirect/Unconjugated Bilirubin Test, Total Serum Bilirubin (TSB), By …

Read More

Global In Vitro Toxicity Testing Market

Global In Vitro Toxicity Testing Market, By Product & Service (Consumables, Assays (Bacterial Toxicity Assays, Enzyme Toxicity Assays, Cell-based …

Read More
Validation error occured. Please enter the fields and submit it again.